Bluejay Diagnostics Inc.
Organization details
- Legal name
- Bluejay Diagnostics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Acton
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- BJDX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001704287
- EIN
- 47-3552922
Board of directors
-
Donald R. Chase · DirectorSince 2023
-
Douglas Clark Wurth · DirectorSince 2023
-
Fred S. Zeidman · DirectorSince 2023
-
Gary G. Gemignani · DirectorSince 2023
-
Indranil Dey · Director · President and CEOSince 2023
-
Svetlana Dey · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.8%
-
89.8%
-
89.8%
-
89.8%
Board connections
1 of this board's directors also sit on 1 other board.
- via Fred S. Zeidman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $221,711
- 6 purchases by 6 insiders
- Sold, last 12 months
- $48,913
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Indranil Dey Director, Officer (President and CEO) | Grant or award | +28,000 | — | — |
| Jul 10, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −34,938 | $1.40 | $48,913 |
| Jul 9, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +64,047 | $1.51 | $96,711 |
| Mar 14, 2026 | Douglas Clark Wurth Director | Open-market purchase | +12,500 | $2.00 | $25,000 |
| Mar 14, 2026 | Indranil Dey Director, Officer (President and CEO) | Open-market purchase | +12,500 | $2.00 | $25,000 |
| Mar 14, 2026 | Donald R. Chase Director | Open-market purchase | +12,500 | $2.00 | $25,000 |
| Mar 14, 2026 | Fred S. Zeidman Director | Open-market purchase | +12,500 | $2.00 | $25,000 |
| Mar 14, 2026 | Svetlana Dey Director | Open-market purchase | +12,500 | $2.00 | $25,000 |
| Dec 13, 2023 | Svetlana Dey Director | Open-market purchase | +500 | $3.07 | $1,535 |
| Dec 13, 2023 | Indranil Dey Director, Officer (President and CEO), 10% owner | Open-market purchase | +500 | $3.27 | $1,635 |
| Mar 28, 2023 | Indranil Dey Director, Officer (President and CEO) | Grant or award | +2,000 | $0.44 | $880 |
| Mar 27, 2023 | Indranil Dey Director, Officer (President and CEO) | Grant or award | +8,000 | $0.44 | $3,520 |
| Mar 24, 2023 | Svetlana Dey Director | Grant or award | +10,000 | $0.44 | $4,400 |
| Feb 1, 2023 | Gary G. Gemignani Director | Grant or award | +27,500 | $0.44 | $12,100 |
| Feb 1, 2023 | Donald R. Chase Director | Grant or award | +27,500 | $0.44 | $12,100 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Bluejay Diagnostics Inc.
Who is the CEO of Bluejay Diagnostics Inc.?
Indranil Dey is Bluejay Diagnostics Inc.'s President and CEO.
How many directors are on Bluejay Diagnostics Inc.'s board?
Bluejay Diagnostics Inc.'s board has 6 directors: Donald R. Chase, Douglas Clark Wurth, Fred S. Zeidman, Gary G. Gemignani, Indranil Dey and Svetlana Dey.
Are Bluejay Diagnostics Inc. insiders buying or selling shares?
Over the last 12 months, Bluejay Diagnostics Inc. insiders bought $221,711 of shares in 6 purchases and sold $48,913 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="bluejay-diagnostics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.